NCT02159807View on ClinicalTrials.gov

Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 24, 2015

Primary Completion Date

December 29, 2017

Study Completion Date

December 29, 2017

Conditions
Pregnancy
Interventions
DRUG

Bupivacaine

The dose of bupivacaine administered intrathecally during placement of the spinal anesthetic.

DRUG

Fentanyl

20 micrograms routinely administered in combination in the spinal anesthetic

Trial Locations (1)

10019

Roosevelt hospital, New York

All Listed Sponsors
lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT02159807 - Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects | Biotech Hunter | Biotech Hunter